Milestone Scientific (MLSS) EBIT (2010 - 2026)

Milestone Scientific has disclosed EBIT across 17 years of filings, most recently posting -$828083.0 for Q1 2026.

• In Q1 2026, EBIT rose 58.55% year-over-year to -$828083.0; the TTM figure through Mar 2026 stood at -$4.5 million (up 38.01% YoY), while the FY2025 annual figure was -$5.7 million, up 16.18% from the prior year.
• EBIT came in at -$828083.0 for Q1 2026 at Milestone Scientific, up from -$1.1 million in the prior quarter.
• In the past five years, EBIT ranged from a high of -$828083.0 in Q1 2026 to a low of -$2.9 million in Q2 2022.
• Average EBIT over 5 years is -$1.7 million, with a median of -$1.8 million recorded in 2024.
• Year-over-year, EBIT sank 94.49% in 2022 and surged 58.55% in 2026.
• Over 5 years, EBIT stood at -$2.0 million in 2022, then gained by 1.74% to -$2.0 million in 2023, then fell by 5.34% to -$2.1 million in 2024, then soared by 48.06% to -$1.1 million in 2025, then advanced by 23.54% to -$828083.0 in 2026.
• Per Business Quant data, the three most recent EBIT figures were -$828083.0 in Q1 2026, -$1.1 million in Q4 2025, and -$1.1 million in Q3 2025.